120 related articles for article (PubMed ID: 2857060)
1. Prenalterol in symptomatic sinus node dysfunction.
Feleke E; Rydén L; Smedgård P; Westerling S
Am Heart J; 1985 Jan; 109(1):185-7. PubMed ID: 2857060
[No Abstract] [Full Text] [Related]
2. [Beta-adrenergic stimulation with prenalterol in sick sinus syndrome].
Treese N; Russ M; Kasper W; Meinertz T; Pop T
Z Kardiol; 1983 Aug; 72(8):481-6. PubMed ID: 6624189
[TBL] [Abstract][Full Text] [Related]
3. Short and long-term effects of hydralazine and combined hydralazine and prenalterol therapy in patients with congestive heart failure.
Drexler H; Löllgen H; Just H
Acta Med Scand Suppl; 1982; 659():315-24. PubMed ID: 6127898
[No Abstract] [Full Text] [Related]
4. Metabolic effects of prenalterol in diabetic patients.
Oltmanns D
Acta Med Scand Suppl; 1982; 659():147-55. PubMed ID: 6127885
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
Hutton I; Tweddel AC; Bastian BC; Murray RG
Acta Med Scand Suppl; 1981; 652():163-8. PubMed ID: 6120615
[No Abstract] [Full Text] [Related]
6. Prenalterol as an antidote to massive doses of metoprolol--a cardiovascular study in the dog.
Andersson T; Heath A; Mattsson H
Acta Med Scand Suppl; 1982; 659():71-88. PubMed ID: 6127900
[No Abstract] [Full Text] [Related]
7. Echocardiographic comparison between prenalterol and dobutamine.
Wester HA; Oltmanns D
Acta Med Scand Suppl; 1982; 659():181-90. PubMed ID: 6127888
[TBL] [Abstract][Full Text] [Related]
8. Prenalterol in the treatment of congestive heart failure developing during beta-blocking therapy. A comparison with frusemide in patients with acute myocardial infarction.
Dahlström U; Karlsson E
Acta Med Scand; 1982; 212(3):125-30. PubMed ID: 6128867
[No Abstract] [Full Text] [Related]
9. Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy.
Erbel R; Meyer J; Lambertz H; Schweizer P; Voelker W; Krebs W; Braun G; Effert S
Circulation; 1982 Aug; 66(2):361-9. PubMed ID: 6124326
[No Abstract] [Full Text] [Related]
10. Electrophysiologic properties of prenalterol.
Capucci A; Frabetti L; Melandri G; Magnani B
Int J Cardiol; 1983; 2(3-4):391-400. PubMed ID: 6132888
[TBL] [Abstract][Full Text] [Related]
11. Intravenous prenalterol in acute and chronic heart failure.
Kirlin PC; Pitt B; Lucchesi BR
Acta Med Scand Suppl; 1982; 659():263-86. PubMed ID: 6127894
[No Abstract] [Full Text] [Related]
12. The hemodynamic actions of prenalterol in left ventricular failure.
Awan NA; Evenson MK; Needham KE; Mason DT
Acta Med Scand Suppl; 1982; 659():251-61. PubMed ID: 6127893
[TBL] [Abstract][Full Text] [Related]
13. Effects of prenalterol administered orally in patients with congestive heart failure.
Hjalmarson A; Abelardo N; Caidahl K; Reyes C; Waagstein F; Wallentin I; Wikstrand J; Estrada-Yamamoto M
Acta Med Scand Suppl; 1982; 659():201-20. PubMed ID: 6127890
[TBL] [Abstract][Full Text] [Related]
14. Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.
Glover DR; Wathen CG; Murray RG; Petch MC; Muir AL; Littler WA
Br Heart J; 1985 Feb; 53(2):208-15. PubMed ID: 2857088
[TBL] [Abstract][Full Text] [Related]
15. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
Guazzi MD; Qing LG; Olivari MT; Fiorentini C; Loaldi A; Bartorelli A; Moruzzi P; Polese A
Acta Med Scand Suppl; 1982; 659():233-50. PubMed ID: 6127892
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic effects of intravenously administered prenalterol in patients with severe heart failure.
Waagstein F; Estrada-Yamamoto M; Reiz S; Reyes C; Hjalmarson A
Acta Med Scand Suppl; 1982; 659():221-31. PubMed ID: 6127891
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of prenalterol in healthy subjects and patients with congestive heart failure.
Rönn O
Acta Med Scand Suppl; 1982; 659():89-98. PubMed ID: 6127901
[TBL] [Abstract][Full Text] [Related]
18. Compartment model of prenalterol.
Klein G; Wirtzfeld A; Bozler G; Rönn O; Graffner C
Acta Med Scand Suppl; 1982; 659():99-107. PubMed ID: 6127903
[TBL] [Abstract][Full Text] [Related]
19. [Circulatory effects of prenalterol (a selective beta-1 agonist) in normal subjects and in patients with primary congestive cardiomyopathy].
Moruzzi P; Cipolla CM; Bartorelli A; Reggiani P; Ging LQ; Guazzi M
Cardiologia; 1982; 27(1):99-101. PubMed ID: 6152733
[No Abstract] [Full Text] [Related]
20. [Effects of Prenalterol on left ventricular function of coronary patients].
Javernaro A; Bolognesi R; Giacometti P; Potenza D; Cortesi G; Cucchini F
Acta Biomed Ateneo Parmense; 1983; 54(1):17-8. PubMed ID: 6134412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]